EBITDA at other companies
Other financials
Where this comes from
Calculated from Charles River Laboratories’s reported figures.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's EBITDA?
- Charles River Laboratories (CRL) reported EBITDA of $187.05M in Q1 2026.
- How has Charles River Laboratories's EBITDA changed year-over-year?
- Charles River Laboratories's EBITDA decreased by 4.1% year-over-year, from $195.03M to $187.05M.
- What is the long-term trend for Charles River Laboratories's EBITDA?
- Over 4 years (2021 to 2025), Charles River Laboratories's EBITDA has grown at a -4.5% compound annual growth rate (CAGR), from $855.4M to $710.81M.
- What does EBITDA mean?
- Operating cash profit before interest, taxes, and non-cash charges.
- How do you interpret EBITDA?
- Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
- How does EBITDA compare across companies?
- Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.